检测认证人脉交流通讯录
阿扎那韦杂质，伊曲康唑杂质 aitraconazole，盐酸倍他洛尔杂质
- 阿扎那韦杂质对照品
Atazanavir-d5，
Des-N-(methoxycarbonyl)-L-tert-leucine Atazanavir Trihydrochloride，
Des-N-(methoxycarbonyl)-L-tert-leucine Atazanavir-d5 Trihydrochloride，
去-N-(甲氧基羰基)-L-tert-亮氨酸 Bis-Boc 阿扎那韦：Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc Atazanavir ， Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc Atazanavir-d5，
阿扎那韦 Atazanavir
（LGC）
伊曲康唑杂质
伊曲康唑杂质A 4-[4-[4-(4-Methoxyphenyl)piperazin-1-yl]phenyl]-2-[(1RS)-1-methylpropyl]-2,4-dihydro-3H-1,2,4-triazol-3-one
伊曲康唑杂质B Itraconazole Impurity B
伊曲康唑杂质C Itraconazole Impurity C
伊曲康唑杂质D Itraconazole Impurity D
伊曲康唑杂质E Itraconazole Impurity E
伊曲康唑杂质F Itraconazole Impurity F
伊曲康唑杂质G Itraconazole Impurity G
伊曲康唑系统稳定性 Itraconazole System Suitability Mixture (25 mg)
伊曲康唑对照品
盐酸倍他洛尔杂质, betaxolol hydrochloride
盐酸倍他洛尔杂质A,Imp. A (EP) as Hydrochloride: (2RS)-
1-(4-Ethylphenoxy)-3-[(1-methylethyl)amino]-propan-2-ol Hydrochloride
盐酸倍他洛尔杂质 B
Imp. B (EP): (2RS)-1-[4-(2-Hydroxyethyl)phenoxy]-3-[(1-methylethyl)amino]propan-2-ol
盐酸倍他洛尔杂质 C
Imp. C (EP): 2-[[4-[2-(Cyclopropylmethoxy)-ethyl]phenoxy]methyl]oxirane
盐酸倍他洛尔杂质 D
Imp. D (EP): 4-[2-(Cyclopropylmethoxy)ethyl]phenol
盐酸倍他洛尔杂质 E
Imp. E (EP) as Hydrochloride: (2RS)-1-[4-(2-Butoxyethyl)phenoxy]-3-[(1-methylethyl)amino]propan-2-ol
Hydrochloride
盐酸倍他洛尔对照品
